Close Menu

NEW YORK — Proteomics International Laboratories said on Friday that it has signed an agreement for the distribution of its Promarker D diabetic kidney disease immunoassay in Italy.

The CE-marked ELISA-based test, called Promarker D (IA), uses protein signatures in blood to detect the onset of kidney disease in type 2 diabetics. It is a high-throughput version of the Australian company's mass spectrometry-based PromarkerD (MS) test. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.